Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations

Yueqiong Ni(Shanghai Jiao Tong University), Weiping Jia(NovaBay Pharmaceuticals (United States)), Gianni Panagiotou(Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI)), Yueliang Zhao(Shanghai Jiao Tong University), Lina Zhou(Nanjing University of Chinese Medicine), Huating Li(Shanghai Sixth People's Hospital), Hani El‐Nezami(University of Eastern Finland), Aimin Xu(University of Hong Kong), Guowang Xu(Dalian Institute of Chemical Physics), Qian Wu(Xi'an Jiaotong University), Sara Leal Siliceo(Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI)), Qiongmei Gao(Shanghai Jiao Tong University), Howell Leung(Applied Science and Technology Research Institute), Rui Yuan(Shanghai Ocean University), Shuangbo Liu(Shanghai Ocean University), Xiaoxue Long(Shanghai Jiao Tong University), Yan Liu(Sun Yat-sen University), Marsena Jasiel Ismaiah(University of Eastern Finland), Qi Li(Chinese Academy of Sciences), Ying Zhang(Shanghai Jiao Tong University), Xiaolin Wang(South China Agricultural University), Xi Jia(Mudanjiang Medical University), Lei Zhang(Southwest Medical University), Lingling Qian(Shanghai Jiao Tong University), Emmanouil Nychas(Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI))
Cell Metabolism
September 1, 2023
Cited by 191


Related Papers